Drug class
Oral dopamine agonist prodrug; dopaminergic and adrenergic vasodilator
Mechanism of action
Hydrolysed by esterases to epinine (N-methyldopamine), which activates D1 and D2 dopaminergic receptors and, to a lesser extent, alpha- and beta-adrenergic receptors. The resulting haemodynamic actions include vasodilation and changes in cardiac loading conditions.
General use cases
- Historically investigated and used in some countries for congestive heart failure; it is not a standard contemporary heart-failure therapy and current marketing authorisation should be checked locally.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
